BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14598859)

  • 1. Insulin resistant states and insulin signaling.
    Vollenweider P
    Clin Chem Lab Med; 2003 Sep; 41(9):1107-19. PubMed ID: 14598859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Knockout mouse models for type 2 diabetes. Mice with insulin resistance].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():64-9. PubMed ID: 12355825
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin signalling and the regulation of glucose and lipid metabolism.
    Saltiel AR; Kahn CR
    Nature; 2001 Dec; 414(6865):799-806. PubMed ID: 11742412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning down insulin signaling.
    Birnbaum MJ
    J Clin Invest; 2001 Sep; 108(5):655-9. PubMed ID: 11544268
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of insulin resistance.
    Schinner S; Scherbaum WA; Bornstein SR; Barthel A
    Diabet Med; 2005 Jun; 22(6):674-82. PubMed ID: 15910615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.
    Esposito DL; Li Y; Vanni C; Mammarella S; Veschi S; Della Loggia F; Mariani-Costantini R; Battista P; Quon MJ; Cama A
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1468-75. PubMed ID: 12679424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Mauvais-Jarvis F; Kahn CR
    Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
    Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
    Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin resistance: from clinical diagnosis to molecular genetics. Implications in diabetes mellitus].
    Jaffiol C; Rouard M; Macari F; Lautier C; Ait el Mkadem S; Méchaly I; Brun JF; Renard E; Cros G; Bringer J; Grigorescu F
    Bull Acad Natl Med; 1999; 183(9):1761-75; discussion 1775-7. PubMed ID: 10987057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of insulin action in normal and insulin-resistant states.
    Le Marchand-Brustel Y
    Exp Clin Endocrinol Diabetes; 1999; 107(2):126-32. PubMed ID: 10320053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome.
    Tepavčević S; Vojnović Milutinović D; Macut D; Žakula Z; Nikolić M; Božić-Antić I; Romić S; Bjekić-Macut J; Matić G; Korićanac G
    J Steroid Biochem Mol Biol; 2014 May; 141():71-6. PubMed ID: 24472754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice.
    Shiuchi T; Iwai M; Li HS; Wu L; Min LJ; Li JM; Okumura M; Cui TX; Horiuchi M
    Hypertension; 2004 May; 43(5):1003-10. PubMed ID: 15037562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular mechanisms underlying increases in glucose uptake in response to insulin or exercise in skeletal muscle.
    Ryder JW; Chibalin AV; Zierath JR
    Acta Physiol Scand; 2001 Mar; 171(3):249-57. PubMed ID: 11412137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanism(s) of burn-induced insulin resistance in murine skeletal muscle: role of IRS phosphorylation.
    Zhang Q; Carter EA; Ma BY; White M; Fischman AJ; Tompkins RG
    Life Sci; 2005 Oct; 77(24):3068-77. PubMed ID: 15982669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance.
    Sylow L; Kleinert M; Pehmøller C; Prats C; Chiu TT; Klip A; Richter EA; Jensen TE
    Cell Signal; 2014 Feb; 26(2):323-31. PubMed ID: 24216610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes.
    Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.